NEW YORK (360Dx) – RPS Diagnostics and Atomo Diagnostics announced today that they have entered into a commercial and developmental partnership to create FebriDx, a point-of-care test that identifies clinically significant underlying febrile acute respiratory infections and aids in the differentiation between viral and bacterial infections.

FebriDx uses a fingerstick blood sample to provide clinicians with a rapid assessment of the body's immune response to acute respiratory infections. The disposable test returns results within 10 minutes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
23
Sponsored by
PerkinElmer

This webinar will address a range of methods for optimizing small RNA library preparation.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.